Skip to content

AIFC AIFC Interest Income (Expense), Nonoperating

Interest Income (Expense), Nonoperating at other companies

Krystal Biotech, Inc. logo
Krystal Biotech, Inc.KRYS
AbbVie logo
AbbVieABBV

Segments

By segment

See full
Total Reportable Segments-$2.75M
Fintech-$379K
Corporate And Other-$256K+60.7%

Other financials

Income statement

See full
Revenue$4.7M-2.8%
Gross profit$3.6M+85.6%
Operating income-$2.7M-41.0%
Net income-$271.5M-11,250%
EPS (diluted)-$2.14-1,327%

Balance sheet

See full
Cash & equivalents$10.5M-2.7%
Total debt$107.0K-99.4%
Total equity$889.7M+3,976%
Total assets$959.7M+1,130%

Cash flow

See full
Operating cash flow-$12.3M-764%
CapEx$2.8K
Free cash flow-$1.8M

Valuation

See full
Market cap$0+43,568%

Profitability

See full
Gross margin46.5%+1.2pp
Operating margin-99.7%-717pp
Net margin-2,552.7%-2,601pp
FCF margin-29.7%

Returns & leverage

See full
Return on equity-134.6%-791pp
Debt / equity-0.5×
Current ratio0.8×0.0×

Where this comes from

Reported directly by AIFC in its filing.

Tagged under the XBRL concept us-gaap:InterestIncomeExpenseNonoperatingNet.

The official record: AIFC’s 10-Q, filed May 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about AIFC's interest income (expense), nonoperating.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AIFC's interest income (expense), nonoperating?
AIFC (AIFC) reported interest income (expense), nonoperating of -$506K in Q1 2026.
How has AIFC's interest income (expense), nonoperating changed year-over-year?
AIFC's interest income (expense), nonoperating increased by 29.7% year-over-year, from -$720K to -$506K.
What is the long-term trend for AIFC's interest income (expense), nonoperating?
Over 2 years (2023 to 2025), AIFC's interest income (expense), nonoperating has grown at a 31.1% compound annual growth rate (CAGR), from $2.25M to -$3.87M.